RECOMBINANT HUMAN INSULIN PRODUCTION TECHNOLOGY
Overview of innovation
The Council for Scientific and Industrial Research (CSIR), in collaboration with its partners, has successfully developed an advanced biomanufacturing process for producing Recombinant Human Insulin. The technology involves microbial fermentation and purification of bulk drug substance, ensuring high-quality standards suitable for therapeutic use.
Type of Intellectual Property protection
Trade secret
Innovation Opportunity Type
Distribution
Funding
Investment
Licensing
Partnership
Industry
Human health and social work activities
Human health activities
Technology Readiness Level
TRL 5 – Prototype tested in a controlled environment